10.2 Acquisition Analysis & Business Combination Valuation Entries

10.2 Acquisition Analysis & Business Combination Valuation Entries

Core Principle: At the date of acquisition, the parent must prepare an acquisition analysis comparing purchase consideration with the fair value of identifiable net assets acquired. In the consolidation worksheet, Business Combination Valuation (BCV) entries restate the subsidiary's identifiable assets and liabilities to fair value net of deferred tax under IAS 12, after which pre-acquisition equity is eliminated against the parent's investment.

Consolidation does not alter the standalone accounting records of the legal parent or legal subsidiary. Instead, consolidation entries exist solely on the consolidation worksheet to produce group financial statements. When a parent acquires a subsidiary, the subsidiary's assets and liabilities are recorded in its own ledger at historical carrying amounts. To present the group as a single entity, the consolidation worksheet must bring those assets and liabilities to fair value at acquisition date and eliminate the reciprocal investment and equity balances.

---

The Acquisition Analysis Architecture

The acquisition analysis is a technical calculation performed at the acquisition date to determine:

1. The carrying amount of the subsidiary's equity at acquisition;
2. The fair value adjustments required to restate identifiable assets and liabilities;
3. The deferred tax consequences under IAS 12; and
4. The resulting Goodwill or Gain on Bargain Purchase.

$$\begin{aligned} \text{Book Value of Subsidiary Equity} &= \text{Share Capital} + \text{Retained Earnings} + \text{Reserves (at acquisition date)} \\[6pt] \text{Identifiable Net Assets at FV} &= \text{Book Value of Equity} + \sum \left[ \text{Pre-Tax FV Adjustments} \times (1 - t) \right] \\[6pt] \text{Goodwill} &= \text{Consideration Transferred} + \text{NCI} - \text{Identifiable Net Assets at FV} \end{aligned}$$

Where $t$ represents the applicable statutory corporate tax rate (e.g., 30% in Australia).

---

Business Combination Valuation (BCV) Entries & Deferred Tax

Under IFRS 3.18, the acquirer must measure all identifiable assets acquired and liabilities assumed at their acquisition-date fair values. Under IAS 12 Income Taxes, adjusting an asset or liability to fair value for consolidation purposes changes its carrying amount in the consolidated financial statements without altering its tax base (which remains governed by historical tax records). This divergence creates a temporary difference that mandates the recognition of deferred tax.

Typical BCV Adjustments and Tax Treatments

Exam Trap: Candidates often ask whether the initial recognition exemption under IAS 12.15(b) prevents recognizing deferred tax on these assets. Under IAS 12.15(b)(i) and 12.24(a), the initial recognition exemption does not apply to business combinations. Deferred taxes must be recognized on all identifiable assets and liabilities adjusted to fair value in a business combination.

Pre-Acquisition Equity Elimination Mechanics

The pre-acquisition elimination entry cancels the parent's asset Investment in Subsidiary against the subsidiary's pre-acquisition equity balances and the after-tax BCV reserve, while recognizing Goodwill (or Gain on Bargain Purchase) and the Non-Controlling Interest at the acquisition date.

The Standard Pre-Acquisition Elimination Entry

Consolidation Journal Entry (Acquisition Date):
Dr   Share Capital (Subsidiary - pre-acquisition)                 [Book Value]
Dr   Retained Earnings (Subsidiary - pre-acquisition)             [Book Value]
Dr   General Reserve (Subsidiary - pre-acquisition)               [Book Value]
Dr   BCV Reserve (Total after-tax fair value adjustments)         [After-Tax FV Step-ups]
Dr   Goodwill (Consolidated asset)                                [Calculated]
     Cr   Investment in Subsidiary (Parent's asset)                           [Purchase Cost]
     Cr   Non-Controlling Interest (NCI at acquisition date)                  [Proportionate or FV]

If the combination produces a gain on bargain purchase (where Identifiable Net Assets at Fair Value exceed Consideration + NCI), the credit is recognized immediately in profit or loss (in the period of acquisition) after a thorough reassessment of fair values.

---

Subsequent-Period Consolidation Entries: Amortization & Realization

In financial periods following the acquisition date, two critical accounting requirements arise:

1. Re-enacting the Past: Because consolidation entries are not recorded in the physical general ledgers of either company, the BCV entries and pre-acquisition elimination entries must be re-entered in every subsequent consolidation worksheet for as long as the parent holds the investment.
2. Accounting for Realization: As the underlying revalued assets are consumed, depreciated, or sold, their fair value step-ups must be recognized in consolidated profit or loss, and the related deferred taxes must be unwound.

1. Undervalued Inventory Sold Post-Acquisition

• In Year of Sale (Year 1): When the undervalued inventory on hand at acquisition date is sold to external customers during Year 1, consolidated cost of goods sold must be increased to reflect the higher acquisition-date fair value:
  • Dr Cost of Sales (P/L) [Gross Step-up]
  • Cr Inventory (Balance Sheet) [Gross Step-up]
  • Dr Deferred Tax Liability (Balance Sheet) [Gross Step-up $\times t$]
  • Cr Income Tax Expense (P/L) [Gross Step-up $\times t$]
• In Subsequent Periods (Year 2 and Beyond): In Year 2, because the inventory was sold in Year 1, the expense affected Year 1 profit. In Year 2, that expense now resides in opening retained earnings:
  • Dr Retained Earnings (opening) [After-tax inventory step-up]
  • Dr Deferred Tax Liability [Tax on step-up]
  • Cr Inventory [Gross step-up] (clearing the original BCV inventory entry)

2. Fair Value Step-Up on Depreciable Plant & Equipment

If plant and equipment is stepped up by $\Delta FV$ at acquisition with a remaining useful life of $N$ years:

• Annual Additional Depreciation: $\text{Annual Depreciation} = \frac{\Delta FV}{N}$
• Annual Tax Unwinding: $\text{Annual Tax Reversal} = \text{Annual Depreciation} \times t$

Consolidation Journal Entry — Year 1 (Current Period Adjustment):
Dr   Depreciation Expense (P/L)                                   [ΔFV / N]
     Cr   Accumulated Depreciation (Balance Sheet)                            [ΔFV / N]
Dr   Deferred Tax Liability (Balance Sheet)                       [(ΔFV / N) × t]
     Cr   Income Tax Expense (P/L)                                            [(ΔFV / N) × t]

In Year 2, the prior year's depreciation resides in opening retained earnings, while the current year's depreciation hits current profit or loss:

Consolidation Journal Entry — Year 2 (Subsequent Period Adjustment):
Dr   Retained Earnings (opening) [Prior year depreciation]        [ΔFV / N]
Dr   Depreciation Expense (P/L) [Current year depreciation]        [ΔFV / N]
     Cr   Accumulated Depreciation (Balance Sheet) [Cumulative 2 years]       [2 × (ΔFV / N)]
Dr   Deferred Tax Liability (Balance Sheet) [Cumulative 2 years]   [2 × (ΔFV / N) × t]
     Cr   Retained Earnings (opening) [Prior year tax reversal]               [(ΔFV / N) × t]
     Cr   Income Tax Expense (P/L) [Current year tax reversal]                [(ΔFV / N) × t]

Comprehensive Worked Case Study: Acquisition Analysis and Multi-Year Consolidation

Transaction Details

On 1 July 2024, Meridian Ltd acquires 80% of the ordinary shares of Terra Ltd for $520,000 cash. Meridian measures Non-Controlling Interest at its proportionate share of Terra's identifiable net assets. The statutory corporate tax rate is 30%.

At 1 July 2024, Terra Ltd's statement of financial position reflects:

• Ordinary Share Capital: $300,000
• Retained Earnings: $150,000
• Total Equity: $450,000

All identifiable assets and liabilities of Terra Ltd are recorded at fair value, with the following exceptions:

• Land: Carrying value $100,000; Fair value $150,000 (Fair value step-up = $50,000).
• Plant & Equipment: Carrying value $160,000; Fair value $200,000 (Fair value step-up = $40,000; remaining useful life = 5 years, straight-line).
• Inventory: Carrying value $70,000; Fair value $90,000 (Fair value step-up = $20,000). All undervalued inventory is sold during FY2025 (year ended 30 June 2025).

Step 1: Acquisition Analysis Schedule (1 July 2024)

$$\begin{aligned} \text{Pre-Tax Fair Value Adjustments} &= \$50\text{K (Land)} + \$40\text{K (Plant)} + \$20\text{K (Inventory)} = \$110,000 \\[4pt] \text{Deferred Tax Liability Recognized} &= \$110,000 \times 30\% = \$33,000 \\[4pt] \text{After-Tax BCV Adjustments} &= \$110,000 - \$33,000 = \$77,000 \\[4pt] \text{Identifiable Net Assets at FV} &= \$450,000 \text{ (Book Equity)} + \$77,000 = \textbf{\$527,000} \end{aligned}$$

Step 2: Consolidation Entries at Acquisition Date (1 July 2024)

Entry 1: Business Combination Valuation (BCV) Entry
Dr   Land                                                         $50,000
Dr   Plant & Equipment                                            $40,000
Dr   Inventory                                                    $20,000
     Cr   Deferred Tax Liability ($110,000 × 30%)                             $33,000
     Cr   BCV Reserve ($110,000 × 70%)                                        $77,000

Entry 2: Pre-Acquisition Equity Elimination Entry
Dr   Share Capital                                               $300,000
Dr   Retained Earnings                                           $150,000
Dr   BCV Reserve                                                  $77,000
Dr   Goodwill                                                     $98,400
     Cr   Investment in Terra Ltd                                            $520,000
     Cr   Non-Controlling Interest ($527,000 × 20%)                          $105,400

Step 3: Consolidation Entries at Year 1 End (30 June 2025)

In the first year post-acquisition, the undervalued inventory is sold, and the plant is depreciated by one year ($40,000 / 5 = $8,000):

Re-enter BCV and Pre-Acquisition Elimination Entries (Entries 1 & 2 above).

Entry 3: Realization of Undervalued Inventory Sold in Year 1
Dr   Cost of Sales (P/L)                                          $20,000
     Cr   Inventory                                                           $20,000
Dr   Deferred Tax Liability ($20,000 × 30%)                        $6,000
     Cr   Income Tax Expense (P/L)                                             $6,000

Entry 4: Additional Depreciation on Plant Step-Up (Year 1)
Dr   Depreciation Expense ($40,000 / 5 years)                      $8,000
     Cr   Accumulated Depreciation                                             $8,000
Dr   Deferred Tax Liability ($8,000 × 30%)                         $2,400
     Cr   Income Tax Expense (P/L)                                             $2,400

Step 4: Consolidation Entries at Year 2 End (30 June 2026)

In Year 2, the prior year's realization adjustments hit opening retained earnings, while Year 2 incurs another $8,000 of plant depreciation:

Re-enter BCV and Pre-Acquisition Elimination Entries (Entries 1 & 2 above).

Entry 5: Prior Year Inventory Realization (Rolled into Opening Retained Earnings)
Dr   Retained Earnings (opening) ($20,000 × 70%)                  $14,000
Dr   Deferred Tax Liability                                        $6,000
     Cr   Inventory                                                           $20,000

Entry 6: Plant Depreciation Adjustments (Cumulative Years 1 & 2)
Dr   Retained Earnings (opening) [Year 1 depreciation]             $8,000
Dr   Depreciation Expense (P/L) [Year 2 current depreciation]      $8,000
     Cr   Accumulated Depreciation [2 years cumulative: $8,000 × 2]           $16,000
Dr   Deferred Tax Liability [2 years cumulative: $16,000 × 30%]    $4,800
     Cr   Retained Earnings (opening) [Year 1 tax benefit]                     $2,400
     Cr   Income Tax Expense (P/L) [Year 2 tax benefit]                        $2,400

The net effect on opening retained earnings is $5,600 ($8,000 Year 1 depreciation less $2,400 Year 1 tax benefit), and the entry balances: debits $20,800 = credits $20,800.

Step 5: Non-Controlling Interest After Acquisition

Because Meridian measured NCI at its proportionate share of identifiable net assets, NCI is entitled to 20% of Terra's post-acquisition equity movements, adjusted for the BCV entries (which form part of Terra's net assets in the group). Assume Terra reports a profit after tax of $90,000 for FY2025 and pays a dividend of $20,000 in June 2025.

Entry 7: NCI Share of Current-Year Profit (FY2025)
Dr   NCI Share of Profit (attribution in P/L)                     $14,080
     Cr   Non-Controlling Interest (equity)                                   $14,080

Entry 8: NCI Share of Dividend Paid (FY2025)
Dr   Non-Controlling Interest (equity)                             $4,000
     Cr   Dividend Paid (Terra)                                               $4,000

NCI at 30 June 2025 = $105,400 (acquisition date) + $14,080 − $4,000 = $115,480. The parent's 80% share of the dividend ($16,000) is eliminated against Meridian's dividend revenue (Section 10.3).

In FY2026, the FY2025 movements sit in opening retained earnings. NCI's share of Terra's adjusted post-acquisition retained earnings at 1 July 2025 is 20% × ($90,000 − $20,000 − $14,000 − $5,600) = 20% × $50,400 = $10,080:

Entry 9: NCI Share of Opening Post-Acquisition Retained Earnings (FY2026)
Dr   Retained Earnings (opening)                                  $10,080
     Cr   Non-Controlling Interest (equity)                                   $10,080

Together with Entry 2 ($105,400), this restores the opening NCI of $115,480. NCI's share of FY2026 profit and dividends is then added using Entries 7 and 8. When there are upstream intragroup sales, the unrealised profit also reduces the subsidiary profit used for NCI (Section 10.4).